- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
A novel strategy for l-arginine production in engineered Escherichia coli ; volume:22 ; number:1 ; day:26 ; month:7 ; year:2023 ; pages:1-13 ; date:12.2023
Microbial cell factories ; 22, Heft 1 (26.7.2023), 1-13, 12.2023
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Nie, Mengzhen
Wang, Jingyu
Zhang, Kechun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12934-023-02145-8
- URN
-
urn:nbn:de:101:1-2023102710154893055331
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nie, Mengzhen
- Wang, Jingyu
- Zhang, Kechun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
L-Arginine in diabetes: clinical and preclinical evidence
Transport of L-Arginine Related Cardiovascular Risk Markers
Pyruvate production using engineered Escherichia coli
Squalene Biosynthesis in Engineered Escherichia Coli
Correction: L-Arginine in diabetes: clinical and preclinical evidence
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Metabolic engineering of Escherichia coli for enhanced arginine biosynthesis
Synthesis of avenanthramides using engineered Escherichia coli
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm